Sherwin-Williams vs Chemours: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Sherwin-Williams Co (SHW)

Q3 202628 Jul – 29 Jul 2026

▲4

Sherwin-Williams beats, raises guidance, and announces 8% price hike

Earnings beat and raised full-year guidance Sherwin-Williams reported second-quarter adjusted earnings of $3.70 per share on $6.79 billion in revenue, beating estimates, and raised its full-year adjusted EPS guidance to a midpoint of $12. The stock jumped 7.5-8.3% as investors welcomed the strong results and outlook.
This is the core new event that directly drove the stock's sharp move this period.
8% price hike to offset raw material inflation The company announced an 8% price increase effective September 1 to counter accelerating raw material inflation, which is expected to reach high single digits in the second half. This supports margins and profitability, a key reason for the stock's rise.
The price hike is a new, specific action that helps explain why the company can maintain profits despite cost pressures.
Market share gains and new account wins Sherwin-Williams attributed its strong growth to aggressive new account wins and share gains, not a broad demand recovery. Its Paint Stores Group saw momentum in Protective and Marine, especially in data centers and semiconductor infrastructure, which boosts revenue and investor confidence.
This shows the company is growing even without a market recovery, a key driver of the raised guidance.
Store optimization and cost savings The company closed 57 underperforming stores and expects restructuring to yield about $17 million in annual savings, with half realized in 2026. It also plans to return to the high end of its 80-100 net new store opening target in 2027, supporting long-term profitability.
These actions improve efficiency and future growth prospects, contributing to the positive outlook.

July 202628 Jul – 29 Jul 2026

▲4

Sherwin-Williams beats, raises guidance, and announces 8% price hike

Earnings beat and raised full-year guidance Sherwin-Williams reported second-quarter adjusted earnings of $3.70 per share on $6.79 billion in revenue, beating estimates, and raised its full-year adjusted EPS guidance to a midpoint of $12. The stock jumped 7.5-8.3% as investors welcomed the strong results and outlook.
This is the core new event that directly drove the stock's sharp move this period.
8% price hike to offset raw material inflation The company announced an 8% price increase effective September 1 to counter accelerating raw material inflation, which is expected to reach high single digits in the second half. This supports margins and profitability, a key reason for the stock's rise.
The price hike is a new, specific action that helps explain why the company can maintain profits despite cost pressures.
Market share gains and new account wins Sherwin-Williams attributed its strong growth to aggressive new account wins and share gains, not a broad demand recovery. Its Paint Stores Group saw momentum in Protective and Marine, especially in data centers and semiconductor infrastructure, which boosts revenue and investor confidence.
This shows the company is growing even without a market recovery, a key driver of the raised guidance.
Store optimization and cost savings The company closed 57 underperforming stores and expects restructuring to yield about $17 million in annual savings, with half realized in 2026. It also plans to return to the high end of its 80-100 net new store opening target in 2027, supporting long-term profitability.
These actions improve efficiency and future growth prospects, contributing to the positive outlook.

Latest28 Jul – 29 Jul 2026

▲4

Sherwin-Williams beats, raises guidance, and announces 8% price hike

Earnings beat and raised full-year guidance Sherwin-Williams reported second-quarter adjusted earnings of $3.70 per share on $6.79 billion in revenue, beating estimates, and raised its full-year adjusted EPS guidance to a midpoint of $12. The stock jumped 7.5-8.3% as investors welcomed the strong results and outlook.
This is the core new event that directly drove the stock's sharp move this period.
8% price hike to offset raw material inflation The company announced an 8% price increase effective September 1 to counter accelerating raw material inflation, which is expected to reach high single digits in the second half. This supports margins and profitability, a key reason for the stock's rise.
The price hike is a new, specific action that helps explain why the company can maintain profits despite cost pressures.
Market share gains and new account wins Sherwin-Williams attributed its strong growth to aggressive new account wins and share gains, not a broad demand recovery. Its Paint Stores Group saw momentum in Protective and Marine, especially in data centers and semiconductor infrastructure, which boosts revenue and investor confidence.
This shows the company is growing even without a market recovery, a key driver of the raised guidance.
Store optimization and cost savings The company closed 57 underperforming stores and expects restructuring to yield about $17 million in annual savings, with half realized in 2026. It also plans to return to the high end of its 80-100 net new store opening target in 2027, supporting long-term profitability.
These actions improve efficiency and future growth prospects, contributing to the positive outlook.

Chemours Co (CC)

Q3 202624 Jun – 7 Aug 2026

▲2▼2

Chemours settles PFAS suits, sets 2026 guidance; new state lawsuits add risk

EPA PFAS settlement removes major regulatory overhang Chemours agreed to pay a $22.5 million penalty and fund $90 million in PFAS mitigation projects, resolving a major federal dispute. The stock jumped 6.1% on the news as investors saw the settlement as a known cost that clears a big legal cloud, making future cash flows more predictable.
This is the period's biggest positive catalyst, directly lifting CC shares by reducing uncertainty.
New York and other states sue over PFAS contamination New York State sued 3M, DuPont, and Chemours spinoffs over PFAS, seeking cleanup costs and penalties. This adds fresh legal risk and potential future payouts, which can weigh on CC's stock because investors worry about unknown liabilities and cash outflows.
It introduces a new legal threat that could increase costs and uncertainty for CC.
2026 guidance shows earnings growth and deleveraging Chemours guided 2026 adjusted EBITDA to $775–$825 million and net leverage to about 3.8x, with Q2 beating expectations on pricing strength and cost cuts. This signals improving profits and a stronger balance sheet, supporting a higher stock price as investors gain confidence in the business.
It provides a forward-looking financial picture that directly influences CC's valuation.
Court approves $2.5 billion New Jersey PFAS settlements A federal judge approved over $2.5 billion in PFAS settlements involving DuPont, 3M, Chemours, and Corteva. While this resolves some claims, it confirms large legacy costs for Chemours, which can pressure the stock as investors factor in the cash outflows.
It finalizes a major liability that affects CC's financial obligations and investor sentiment.

July 202624 Jun – 7 Aug 2026

▲2▼2

Chemours settles PFAS suits, sets 2026 guidance; new state lawsuits add risk

EPA PFAS settlement removes major regulatory overhang Chemours agreed to pay a $22.5 million penalty and fund $90 million in PFAS mitigation projects, resolving a major federal dispute. The stock jumped 6.1% on the news as investors saw the settlement as a known cost that clears a big legal cloud, making future cash flows more predictable.
This is the period's biggest positive catalyst, directly lifting CC shares by reducing uncertainty.
New York and other states sue over PFAS contamination New York State sued 3M, DuPont, and Chemours spinoffs over PFAS, seeking cleanup costs and penalties. This adds fresh legal risk and potential future payouts, which can weigh on CC's stock because investors worry about unknown liabilities and cash outflows.
It introduces a new legal threat that could increase costs and uncertainty for CC.
2026 guidance shows earnings growth and deleveraging Chemours guided 2026 adjusted EBITDA to $775–$825 million and net leverage to about 3.8x, with Q2 beating expectations on pricing strength and cost cuts. This signals improving profits and a stronger balance sheet, supporting a higher stock price as investors gain confidence in the business.
It provides a forward-looking financial picture that directly influences CC's valuation.
Court approves $2.5 billion New Jersey PFAS settlements A federal judge approved over $2.5 billion in PFAS settlements involving DuPont, 3M, Chemours, and Corteva. While this resolves some claims, it confirms large legacy costs for Chemours, which can pressure the stock as investors factor in the cash outflows.
It finalizes a major liability that affects CC's financial obligations and investor sentiment.

Latest24 Jun – 7 Aug 2026

▲2▼2

Chemours settles PFAS suits, sets 2026 guidance; new state lawsuits add risk

EPA PFAS settlement removes major regulatory overhang Chemours agreed to pay a $22.5 million penalty and fund $90 million in PFAS mitigation projects, resolving a major federal dispute. The stock jumped 6.1% on the news as investors saw the settlement as a known cost that clears a big legal cloud, making future cash flows more predictable.
This is the period's biggest positive catalyst, directly lifting CC shares by reducing uncertainty.
New York and other states sue over PFAS contamination New York State sued 3M, DuPont, and Chemours spinoffs over PFAS, seeking cleanup costs and penalties. This adds fresh legal risk and potential future payouts, which can weigh on CC's stock because investors worry about unknown liabilities and cash outflows.
It introduces a new legal threat that could increase costs and uncertainty for CC.
2026 guidance shows earnings growth and deleveraging Chemours guided 2026 adjusted EBITDA to $775–$825 million and net leverage to about 3.8x, with Q2 beating expectations on pricing strength and cost cuts. This signals improving profits and a stronger balance sheet, supporting a higher stock price as investors gain confidence in the business.
It provides a forward-looking financial picture that directly influences CC's valuation.
Court approves $2.5 billion New Jersey PFAS settlements A federal judge approved over $2.5 billion in PFAS settlements involving DuPont, 3M, Chemours, and Corteva. While this resolves some claims, it confirms large legacy costs for Chemours, which can pressure the stock as investors factor in the cash outflows.
It finalizes a major liability that affects CC's financial obligations and investor sentiment.